US67086U3077 - Common Stock
OLB GROUP INC
NASDAQ:OLB (5/8/2024, 10:06:59 AM)
4.34
+0.31 (+7.69%)
The OLB Group, Inc. is a FinTech company, which focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. The company is headquartered in New York City, New York and currently employs 26 full-time employees. The company went IPO on 2005-11-18. Its eCommerce platform delivers cloud-based merchant services for a comprehensive digital commerce solution to over 10,300 merchants in diversified market sectors in all 50 states. Its business functions through three subsidiaries, eVance, Inc. (eVance), OmniSoft.io, Inc. (OmniSoft), and CrowdPay.Us, Inc. (CrowdPay). OmniSoft operates a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses. eVance provides competitive payment processing solutions to merchants, which enable merchants to process credit and debit card-based internet payments for sales of their products. CrowdPay.US operates a white label capital raising platform that targets small and midsized businesses seeking to raise capital. DMint, a subsidiary of the Company, is engaged in the mining of Bitcoin in Tennessee.
OLB GROUP INC
1120 Avenue Of The Americas, 4th Floor
New York City NEW YORK 10166
P: 12122780900
CEO: Ronny Yakov
Employees: 26
Website: https://olb.com/
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Tuesday!
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Volume analysis on 2024-04-23: stocks with an unusual volume in today's session.
Hepion Pharmaceuticals stock is falling on Monday as investors in HEPA learn of the company winding down a Phase 2b clinical trial.
Vaxxinity stock is falling hard on Monday after the company announced plans to voluntarily delist shares of VAXX stock next month.
Here you can normally see the latest stock twits on OLB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: